SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-117538
Filing Date
2022-04-25
Accepted
2022-04-25 16:07:56
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d344565ddefa14a.htm DEFA14A 47349
2 GRAPHIC g344565g51w11.jpg GRAPHIC 803
3 GRAPHIC g344565g70j12.jpg GRAPHIC 1787
4 GRAPHIC g344565g91i19.jpg GRAPHIC 769
5 GRAPHIC g344565grp001.jpg GRAPHIC 3997
6 GRAPHIC g344565snap0008.jpg GRAPHIC 812
  Complete submission text file 0001193125-22-117538.txt   60185
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36076 | Film No.: 22849758
SIC: 2836 Biological Products, (No Diagnostic Substances)